Navigation Links
Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
Date:10/3/2011

BURLINGTON, Mass., Oct. 3, 2011 /PRNewswire/-- Coronado Biosciences, Inc. today announced the appointment of Noah D. Beerman as Executive Vice President and Chief Operating Officer effective September 26, 2011.

Dr. Bobby W. Sandage, Jr., Coronado's President and CEO, said, "Noah brings with him a breadth of experience from an extensive career holding senior management positions in the industry. With his leadership and expertise in business operations, corporate development, and financing emerging biopharmaceutical companies, he will be a key asset as we execute the Company's business plan, work to maximize shareholder value, and increase our visibility. We are pleased to welcome him to the Coronado team at such an exciting time for the Company."

Mr. Beerman has over 25 years experience in the biopharmaceutical industry. Before joining Coronado as a consultant in May 2011, Mr. Beerman served as President and Chief Executive Officer and a Director of Galena Biopharma, formerly RXi Pharmaceuticals Corporation, from November 2009 until April 2011 where he successfully completed two equity financings, significantly improved Wall Street visibility for the company, and developed and implemented a focused therapeutic and clinical strategy.  Prior to joining RXi, he spent more than 10 years at Indevus Pharmaceuticals, Inc. serving most recently as Executive Vice President, Chief Business Officer from September 2004 until the sale of the company to Endo Pharmaceuticals, Inc. in 2009. Mr. Beerman holds an M.B.A. from Northeastern University's High Technology Program graduating Beta Gamma Sigma, and a B.S. in molecular genetics from the University of Rochester graduating Phi Beta Kappa, Magna Cum Laude. 

About Coronado BiosciencesCoronado Biosciences is engaged in the development of novel immunotherapy biologic agents.  The Company's two principal pharmaceutical product candidates in clinical development are: CNDO-201, a bio
'/>"/>

SOURCE Coronado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
2. Coronado Biosciences Closes $25.8M in Series C Financing
3. Coronado Biosciences Files to Become a Public Reporting Company
4. Coronado Biosciences to Present at the Rodman & Renshaw Annual Global Investment Conference
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
11. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... conference call to report its second quarter 2014 financial ... and outlook on Thursday, August 7, 2014 at 8:30 ... The call can be accessed by dialing ... prior to the start of the call and providing ...
(Date:7/24/2014)... MADISON, Wis. , July 24, 2014 /PRNewswire/ ... provides specialty and compounded pharmaceuticals, announced that it ... sensitivity information unique to each individual based upon ... now possible by understanding the interaction between a ... "We,re very excited to provide this ...
(Date:7/24/2014)... Deutschland, und MARSEILLE , ... , Weltweite Exklusivlizenz der ... QIAGEN die Entwicklung von Tests auf SF3B1-Mutationen, ... Neuer Test weist Mutationen des ... (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf vermuten lassen  ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
... QUEBEC CITY, Oct. 2 /PRNewswire-FirstCall/ - AEterna Zentaris ... biopharmaceutical company focused on,endocrine therapy and oncology, today ... patient recruitment for its Phase 2 trial in ... agonist,linked to doxorubicin. The decision to enter the ...
... integrated neurohormonal ... to obesity pharmacotherapy, SAN DIEGO, Oct. 1 Amylin ... for its pipeline obesity,candidates will be presented at the 2008 ... The Obesity Society,s annual,meeting is one of the largest and ...
Cached Medicine Technology:AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7
(Date:7/24/2014)... of Association Executives (ASAE) announced its 2014 Power of ... American Society of Anesthesiologists (ASA). , The ASA ... A Gold Award, one of the top honors from ... of the world through education on the global anesthesia ... care. , ASA was also honored with a Power ...
(Date:7/24/2014)... NJ (PRWEB) July 24, 2014 ... leading specialist in hematology and oncology, Dr. Hitendra ... Group. Our system welcomes Dr. Upadhyaya to the ... comprise CarePoint Health Medical Group, a comprehensive network ... representing a wide range of specialties. This latest ...
(Date:7/24/2014)... Kathleen Doheny HealthDay Reporter ... obese children often don,t view their kids as unhealthy or ... to a new study. The children of the families ... at the Hasbro Children,s Hospital in Providence, R.I. "A ... said study researcher Dr. Kyung Rhee, now an assistant professor ...
(Date:7/24/2014)... head and neck cancer (HNC). Evidence suggests certain cancers are ... HNC in patients with DM has not been well explored. ... type of cancer. It accounts for about 6 percent of ... and 350,000 cancer deaths worldwide each year. , The authors ... risk of HNC in patients with DM. The authors compared ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Pools and beaches ... the water can be dangerous, especially for small children, so ... water safety. , According to the Centers for Disease Control ... are most at risk for water-related injuries and deaths. It’s ... safe around water, so Amica is offering the following tips ...
Breaking Medicine News(10 mins):Health News:Dr. Upadhyaya Joins CarePoint Health Medical Group 2Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2
... ... our nation. HOPSports and Hyper Wear are teaming up to reach Physical Education students ... with Hyper Wear,s safe and effective SandBell® weights. , ... Valencia, CA and Austin, TX (PRWEB) June 29, 2010 -- ...
... ... or Washing Up on Coastal Shores , ... Mission Viejo, California (Vocus) June 28, 2010 -- SafeShot Technologies, LLC , ... by accidental needlesticks and global reuse of contaminated syringes. The recent oil spill in the ...
... oil spill in the Gulf of Mexico, and they are concerned ... to new data from a continuing survey conducted by the University ... consumer confidence poll conducted by The Food Industry Center at the ... respondents said they were aware of the spill and 85 percent ...
... ... by the body and normally known as a neurotransmitter, and is influenced by the amount ... international team led by researchers at UCSF. , ... (Vocus) June 28, 2010 -- The cause of diabetes during pregnancy is ...
... backyard mosquito bites may come down to leaving the vacuuming ... than vacuuming the grass clippings out of catch basins before ... waste in place, the research found. "Catch basins are ... S-methoprene in cleaned catch basins we saw an average of ...
... research project at the University of Leicester is set to ... to invasive autopsies, which many families find to be unpleasant. ... Midlands Forensic Pathology Unit has won a substantive award by ... develop the use of cardiac angiography in relation to near ...
Cached Medicine News:Health News:HOPSports, Inc. Adds SandBell to Award-Winning Training System 2Health News:HOPSports, Inc. Adds SandBell to Award-Winning Training System 3Health News:SafeShot Technologies Calls on Healthcare Industry to Clean Up Environment & Eliminate Death and Suffering Caused by Contaminated Syringes 2Health News:SafeShot Technologies Calls on Healthcare Industry to Clean Up Environment & Eliminate Death and Suffering Caused by Contaminated Syringes 3Health News:SafeShot Technologies Calls on Healthcare Industry to Clean Up Environment & Eliminate Death and Suffering Caused by Contaminated Syringes 4Health News:Gestational Diabetes Linked to Serotonin and Dietary Protein 2Health News:Gestational Diabetes Linked to Serotonin and Dietary Protein 3Health News:Gestational Diabetes Linked to Serotonin and Dietary Protein 4Health News:Gestational Diabetes Linked to Serotonin and Dietary Protein 5Health News:York U study finds better way to battle mosquitoes 2
ISYSTEM-ABDv2™A/B Scan unit. True Geometry With Stepped Zoom, Pan, Freeze Frame, Post Image Processing....
... The COMPACT Portable II A/B ... images close to analog quality. ... simply nothing like it. Keep ... system or take it to ...
... a true breakthrough in ophthalmic ultrasound, offering ... diagnostic capability previously unavailable. See pathology formerly ... gain up to 105db to view vitreous ... standard 90db setting - or reduce it ...
The P45 Ultrasonic Workstation provides the highest ultrasound resolution for imaging....
Medicine Products: